Let’s pretend shorts / naysayers…
Let’s pretend:
1) The MOS for the 2nd Line Lung Cancer trial comes out approaching or “beyond doubling” the SOC numbers. Somehow, I won’t be surprised that on Sept 7th, the speaker trots up to the microphone and announces “ Today, I would like to share with you the MOS results for our 2nd line Lung Cancer trial….but I can’t since that metric hasn’t been reached.” Even if it has by that date, it will blow away the SOC.
2) The front line Lung Cancer MOS announcement trucks right by Thanksgiving, Christmas and New Years….unannounced.
3) The Pancreatic Cancer data starts giving onlookers hints that the results will be stellar as well.
4) The FDA finally returns a favorable decision to Peregrine regarding moving Cotara forward with a PIII trial.
5) PPHM secures a bridge loan for $20-$30M that allows the data for the above trials to mature further and strengthens their bargaining position.
6) The “infamous signal seeking” phase II trial breast cancer results were legitimate. I have witnessed droves of Bob Uecher look-a likes sitting at the top row of the right field bleachers screaming out “He missed the tag” to the home plate umpire by proclaiming the patients were “cherry picked…and that data can’t be trusted…..and on and on.
7) The Cotara results witnessed in India ie the(18 mos survival) weren’t an anomaly but were the result a highly skilled doctor who found a methodology for catheter placement that can be replicated with his training.
8) The liver cancer trial returns favorable results
9) A vertex/ribaviron/bavi type HCV trial gets funded…..but this time with a way longer tracking period.
Still want to stand on the tracks with the train whistle blowing and your thumbs in your ears wagging your hands with your tongue out? Go for it.
The market cap as it stands today is still a joke.
Oh what heights we’ll hit…
On with the show this is it!!!!!!!!
